Physician profile
Allison Weinkle
NPI 1619323755
$1,355.86
in general payments reported to CMS, 2019-2025
12 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $69.13 · 2021: $325 · 2022: $422 · 2023: $102 · 2024: $214 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $444.94 | 2020-2022 | |
| Abbvie INC. | $281.98 | 2019-2023 | Botox |
| Revance Therapeutics, INC. | $213.61 | 2024-2025 | Daxxify |
| Merz North America, INC. | $137.50 | 2021-2022 | |
| Bioventus LLC | $59.48 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.63 | 2022-2023 | Spevigo |
| Biofrontera INC. | $46.40 | 2022 | |
| Galderma Laboratories, L.P. | $32.84 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $32.31 | 2024-2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $25.99 | 2025 | Fraxel |
| Regeneron Healthcare Solutions, INC. | $20.30 | 2024 | Libtayo |
| Smith+Nephew, INC. | $13.88 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Weinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.